Holen Sie sich die Stockscreener-App
1.63
13.19%
0.19
Handel nachbörslich:
1.78
0.15
+9.20%
Schlusskurs vom Vortag:
$1.44
Offen:
$1.4
24-Stunden-Volumen:
70,113
Relative Volume:
1.36
Marktkapitalisierung:
$8.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.47M
KGV:
-1.6633
EPS:
-0.98
Netto-Cashflow:
$-24.56M
1W Leistung:
-32.64%
1M Leistung:
-38.26%
6M Leistung:
-56.18%
1J Leistung:
-77.67%
1-Tages-Spanne:
$1.3595
$1.76
1-Wochen-Bereich:
$1.3595
$2.575
52-Wochen-Spanne:
$1.3595
$13.61
Evaxion Biotech A S Adr Stock (EVAX) Company Profile
Firmenname
Evaxion Biotech A S Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie EVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| EVAX | 1.63 | 8.65M | 0 | -24.47M | -24.56M | -0.98 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Evaxion Biotech A S Adr Aktie (EVAX) Neueste Nachrichten
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
Evaxion appeals Nasdaq delisting determination - Investing.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply Friday, Up 2.7% for Week - MSN
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1 - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Evaxion Biotech Reports Q3 Progress and Financials - TipRanks
European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5% - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise Friday - MSN
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN
Evaxion reports improved AI vaccine target predictions - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN
Evaxion Biotech A/S ADR (EVAX) Stock: From Low to High in 52 Weeks - The InvestChronicle
EVAX’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Evaxion Biotech inks vaccine licensing deal with MSD - Investing.com
Evaxion stock jumps on expanded vaccine development pact with MSD (NASDAQ:EVAX) - Seeking Alpha
H.C. Wainwright keeps buy rating on Evaxion stock, cites promising AI-powered cancer vaccine - Investing.com
Evaxion Biotech enhances AI vaccine discovery platform - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
Evaxion reports promising phase 2 trial results for cancer vaccine - Investing.com
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - MSN
Evaxion reports high response rate in melanoma trial - Investing.com
Evaxion reports breakthrough in gonorrhea vaccine research - Investing.com
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN
Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com India
Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now - MSN
European Equities Traded in the US as American Depositary Receipts Move Lower in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Down 4% - MSN
European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday - MSN
MSN - MSN
CVB Financial Corp secures key executives with new employment agreements By Investing.com - Investing.com India
Cathie Wood's ARK ETF adjusts portfolio with key stock trades on July 8 By Investing.com - Investing.com
Winmill & Co. buys shares of Bexil Investment Trust worth over $12k By Investing.com - Investing.com
Evaxion Biotech reports progress in AI-powered vaccine development By Investing.com - Investing.com UK
European Equities Traded in the US as American Depositary Receipts Lower Tuesday - MSN
Finanzdaten der Evaxion Biotech A S Adr-Aktie (EVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):